EMES2 PHARMACEUTICALS, LLC — United States · Federal contract register · Supplier record: 21 contracts, all years ($446,305 · Mar 2021 – Sep 2026); $124K since January 2024 (12 contracts · 3 agencies); — rank in the line (of 94 suppliers · 0.0%); 13 agencies never served ($10.3M on the line without EMES2 PHARMACEUTICALS, LLC).
Assay record ASY-US-02COCLT0H7 · Cite as: Assay Systems, “EMES2 PHARMACEUTICALS, LLC: 12 government contracts in the United States since 2024”, https://assay-systems.com/register/us/emes2-pharmaceuticals-llc/
21
contracts, all years
$446,305 · Mar 2021 – Sep 2026
$124K
since January 2024
12 contracts · 3 agencies
—
rank in the line
of 94 suppliers · 0.0%
13
agencies never served
$10.3M on the line without EMES2 PHARMACEUTICALS, LLC
Own record by year
2021 onward
$311K
$11.5K
$36.4K
$42.1K
$45.8K
202120222023202420252026
Who buys from EMES2 PHARMACEUTICALS, LLC
since January 2024
3agencies
$124Kpaid
42.6%top buyer
Department of Health and Human Services42.6%
$53,000
Department of Veterans Affairs37.7%
$46,890
Department of Justice19.6%
$24,390
Won without a rival
2023-11-22 – 2026-09-11
7uncontested awards
39%of its awards
4without a competition
3single bid
EMES2 PHARMACEUTICALS, LLC won 7 of its 18 public contract awards in United States without a rival from 2023-11-22 to 2026-09-11, worth $170K: 4 without a competition and 3 after a competition that drew a single bid. 3 buyers awarded it without a rival, the largest Indian Health Service with 3.
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.